[NRIX] YoY Quarter Result on 31-Aug-2023 [#Q3]

Stock
[NRIX] Nurix Therapeutics, Inc.
Announcement Date
12-Oct-2023
Financial Year
2023
Quarter
31-Aug-2023 [#Q3]
Profit Trend
QoQ- -69.73%
YoY- 17.27%
Quarter Report
NRIX's Result
NRIX's Financial Summary
View:
Show?
Quarter Result
31/08/24 31/08/23 31/08/22 31/08/21 31/08/20 31/08/19 CAGR
Revenue 12,588 18,467 10,791 10,252 4,085 10,580 3.53%
PBT -48,874 -36,982 -45,709 -28,958 -18,517 -2,417 82.33%
Tax 82 3,424 -1,009 -123 -675 10 52.25%
NP -48,956 -36,982 -44,700 -28,835 -18,517 -2,427 82.24%
Tax Rate - - - - - - -
Total Cost 61,544 55,449 55,491 39,087 22,602 13,007 36.41%
Ratio Analysis
31/08/24 31/08/23 31/08/22 31/08/21 31/08/20 31/08/19 CAGR
NP Margin -388.91 -200.26 -414.23 -281.26 -453.29 -22.94 76.02%
Per Share
31/08/24 31/08/23 31/08/22 31/08/21 31/08/20 31/08/19 CAGR
EPS -0.67 -0.68 -0.88 -0.65 -1.09 -0.12 40.99%
EPS Diluted -0.67 -0.68 -0.88 -0.65 -1.09 -0.12 40.99%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.